下一代益生菌市場：按菌株、應用和地區分類的規模、佔有率、前景和機會分析（2025-2032 年）

Next Generation Probiotics Market, by Bacterial Candidate, by Application, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，新一代益生菌市場規模將達到 2.573 億美元，到 2033 年將達到 5.479 億美元。預計 2026 年至 2033 年的複合年成長率將達到 11.4%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	2.573億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	11.40%	2033年市場規模預測：	5.479億美元

新一代益生菌（NGP），或稱為生物治療藥物，是指旨在用作「活體藥物」以治療、治癒或診斷疾病的微生物。它們與傳統益生菌的不同之處在於，前者更有可能在法律規範下註冊。目前，傳統益生菌主要用作機能性食品或膳食補充劑，而新一代益生菌主要用作治療藥物，因此需要經過所有報名手續和臨床試驗。

隨著新一代益生菌的應用領域不斷發展，預計新一代益生菌市場將進一步成長。新一代益生菌的知名應用領域包括藥物給藥、疫苗遞送、免疫調節（增強免疫系統）、精神益生菌（治療精神疾病）、癌症治療和預防、壓力耐受、抗菌化合物的生產以及腸道感染疾病發病機制的闡明。

市場動態

市場新進業者正致力於從投資者資金籌措，以開發新一代益生菌產品，預計這將推動預測期內的市場成長。例如，2019年5月，生技公司Whole Biome（現更名為Pendulum）宣布獲得3,500萬美元的B輪資金籌措，投資者包括創業投資公司紅杉資本。該公司利用這筆資金加速取得專利的產品的商業化進程，拓展藥物研發管線，並增加其專有微生物組干預療法的臨床試驗。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本報告根據以下參數介紹了全球下一代益生菌市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份「全球下一代益生菌市場」報告面向業界的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用分析全球下一代益生菌市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

Pendulum
Amsterdam Winclove Probiotics
Metabogen AB（Biogaia）
Exeliom Biosciences
TargEDys
Chr. Hansen Holding A/S
YSOPIA Bioscience
A-Mansia Biotech
Next Gen Probiotics
Evolve Biosystems
DuPont de Nemours, Inc.

第8章

調查方法
關於本公司

簡介目錄

Product Code: CMI5468

Next Generation Probiotics Market is estimated to be valued at USD 257.3 Mn in 2026 and is expected to reach USD 547.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 257.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.40%	2033 Value Projection:	USD 547.9 Mn

Next generation probiotics (NGP) or live biotherapeutics are organisms that have been designed to be used as living medicines to treat, cure or diagnose disease. They differ from traditional probiotics in that they are likely to be registered under a drug regulatory framework. At present, conventional probiotics are used as either functional foods or as supplements, whereas next generation probiotics are mainly used as therapeutics and hence are subject to the full range of registration processes and clinical trials.

The next generation probiotics market is expected to gain further traction, with evolving applications which signifies the new genera of probiotics. The well recognized applications of next generation probiotics are drug administration, vaccine delivery, immunomodulation (boosting the immune system), psychobiotics (for the treatment of mental disorders), cancer treatment and prevention, stress tolerance, production of antimicrobial compounds, to understand the pathogenesis of enteric infections.

Market Dynamics

Market players are focused on raising funds from investors for the development of next generation probiotics which is expected to drive market growth over the forecast period. For instance, in May 2019, Whole Biome (now Pendulum), a biotechnology company, announced that it had secured US$ 35 million in Series B financing, which was funded by investor Sequoia Capital, a venture capital company and others. The company had used the funds to advance the commercialization of its patented product, expand its discovery pipeline, and scale clinical trials for their novel microbiome interventions.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global next generation probiotics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global next generation probiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global next generation probiotics market

Detailed Segmentation:

Global Next Generation Probiotics Market, By Bacterial Candidate (Revenue, USD Mn, 2021 - 2033)
Akkermansia
Clostridium species
Bifidobacterium species
Lactobacillus species
Others (Faecalibacterium, Christensenella,etc.)
Global Next Generation Probiotics Market, By Application (Revenue, USD Mn, 2021 - 2033)
Weight Management
Glucose Management
Inflammatory Bowel Diseases
Others (Obesity, Metabolic Diseases, etc.)
Global Next Generation Probiotics Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- By Country
  - U.S.
  - Canada
Latin America
- By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Country
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Region/Country
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Pendulum
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Amsterdam Winclove Probiotics
Metabogen AB (Biogaia)
Exeliom Biosciences
TargEDys
Hansen Holding A/S
YSOPIA Bioscience
A-Mansia Biotech
Next Gen Probiotics
Evolve Biosystems
DuPont de Nemours, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Bacterial Candidate
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Collaboration Scenario
Epidemiology
Acquisitions and Partnerships Scenario
Technology Developments
Regulatory Scenario
Technical Challenges
PEST Analysis

4. Global Next Generation Probiotics Market, By Bacterial Candidate, 2021 - 2033, (US$ Million)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Akkermansia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Clostridium species
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Bifidobacterium species
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Lactobacillus species
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others (Faecalibacterium, Christensenella,etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Next Generation Probiotics Market, By Application, 2021 - 2033, (US$ Million)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Weight Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Glucose Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Inflammatory Bowel Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others (Obesity, Metabolic Diseases, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Next Generation Probiotics Market, By Region, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bacterial Candidate, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bacterial Candidate, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bacterial Candidate, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bacterial Candidate, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bacterial Candidate, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bacterial Candidate, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Pendulum
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amsterdam Winclove Probiotics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Metabogen AB (Biogaia)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Exeliom Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
TargEDys
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chr. Hansen Holding A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
YSOPIA Bioscience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
A-Mansia Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Next Gen Probiotics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Evolve Biosystems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
DuPont de Nemours, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies